Doctor profile · Federal record

Dr. Mark Agulnik, MD

Medical Oncology Physician (CMS: Medical Oncology) · Medical Oncology Physician · Los Angeles, CA

  • NPI 1164448734
  • Accepts Medicare
  • MIPS 91.9 / 100 · 2023
  • 28 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1441 Eastlake Ave
Los Angeles, CA 900893012
(323) 865-3000
Mailing address
Po Box 31309
Los Angeles, CA 900310309

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
May 8, 2024
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State licenses (2)
California #C170270 · Illinois #036-118071

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1164448734. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
529
Distinct HCPCS
5
Medicare allowed
$74,157
HCPCS Description Services Patients Avg allowed
99215 Established patient office or other outpatient visit, 40-54 minutes 287 105 $151
99214 Established patient office or other outpatient visit, 30-39 minutes 129 73 $103
99205 New patient office or other outpatient visit, 60-74 minutes 52 52 $190
99214 Established patient office or other outpatient visit, 30-39 minutes 33 26 $103
99215 Established patient office or other outpatient visit, 40-54 minutes 28 26 $151

In context: peer comparison

Among 16 peers in Los Angeles Medical Oncology Physician, average services per provider: 143. This provider delivers 3.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$67,677
Transactions
78
Manufacturers
9
Payer (manufacturer) Industry Txns Amount
Deciphera Pharmaceuticals INC. 30 $31,035.83
SpringWorks Therapeutics, INC. 13 $14,557.01
Boehringer Ingelheim Pharmaceuticals, INC. 11 $11,936.76
Daiichi Sankyo INC. 16 $9,015.40
Lantheus Medical Imaging, INC. 1 $800.00
Aadi Bioscience, INC. 3 $220.24
Tempus Ai, INC 2 $57.77
Regeneron Healthcare Solutions, INC. 1 $33.46
AstraZeneca Pharmaceuticals Lp 1 $20.68

By nature of payment

Consulting Fee
$35,703
Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$14,728
Travel and Lodging
$11,189
Honoraria
$3,570
Food and Beverage
$2,488

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
220
Patients
53
Total drug cost
$920,849
Drug Type Claims Patients Total cost
Imatinib Mesylate Generic 46 0 $94,064
Votrient (Pazopanib Hcl) Brand 33 0 $502,906
Dexamethasone Generic 27 15 $364
Ondansetron Hcl Generic 18 11 $128
Prochlorperazine Maleate Generic 18 16 $247
Lorazepam Generic 14 11 $117
Ondansetron Odt (Ondansetron) Brand 14 0 $216
Furosemide Generic 13 0 $48
Spironolactone Generic 13 0 $134
Granisetron Hcl Generic 12 0 $11,597

Frequently asked questions

Auto-generated from federal data
What is Dr. Mark Agulnik's medical specialty?
Dr. Mark Agulnik practices Medical Oncology Physician in Los Angeles, CA.
Where does Dr. Mark Agulnik practice?
Dr. Mark Agulnik practices at 1441 Eastlake Ave, Los Angeles, CA 900893012. Office phone: 3238653000.
What is Dr. Mark Agulnik's NPI?
Dr. Mark Agulnik's National Provider Identifier (NPI) is 1164448734, issued by NPPES.
Does Dr. Mark Agulnik accept Medicare assignment?
Yes. Dr. Mark Agulnik accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Agulnik commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.